TRIM28 facilitates diffuse large B-cell lymphoma progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis

Liuyan Xin, An Li, Wei Xiao, Jiaqi Yu, Feilin Wang

Open source

DOI
10.1007/s00210-026-05937-y
Published
2026-09-19
Container
Naunyn-Schmiedeberg's Archives of Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05937-y,
  title = {TRIM28 facilitates diffuse large B-cell lymphoma progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis},
  author = {Liuyan Xin and An Li and Wei Xiao and Jiaqi Yu and Feilin Wang},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  doi = {10.1007/s00210-026-05937-y},
  url = {https://doi.org/10.1007/s00210-026-05937-y}
}

RIS

TY  - JOUR
TI  - TRIM28 facilitates diffuse large B-cell lymphoma progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis
AU  - Liuyan Xin
AU  - An Li
AU  - Wei Xiao
AU  - Jiaqi Yu
AU  - Feilin Wang
PY  - 2026
JO  - Naunyn-Schmiedeberg's Archives of Pharmacology
DO  - 10.1007/s00210-026-05937-y
UR  - https://doi.org/10.1007/s00210-026-05937-y
ER  - 

APA

Xin, L., Li, A., Xiao, W., Yu, J., & Wang, F. (2026). TRIM28 facilitates diffuse large B-cell lymphoma progression by inducing glycolytic reprogramming through the E2F1/PKM2 axis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05937-y

Source records